Buffers for Controlling the pH of Bone Morphogenetic Proteins
    1.
    发明申请
    Buffers for Controlling the pH of Bone Morphogenetic Proteins 审中-公开
    缓释剂用于控制骨形态发生蛋白的pH值

    公开(公告)号:US20130172254A1

    公开(公告)日:2013-07-04

    申请号:US13615829

    申请日:2012-09-14

    IPC分类号: C07K14/51

    摘要: The present invention provides formulations of cysteine knot proteins, including TGF-β superfamily proteins and bone morphogenic proteins that are pH stabilized. In particular, the present invention relates to the observation that certain buffers enhance the stability of cysteine knot proteins, including TGF-β superfamily proteins and bone morphogenic proteins. In particular, disclosed herein are liquid and lyophilized formulations prepared with a glycylglycine and tartaric acid buffers to stabilize the pH of the formulation.

    摘要翻译: 本发明提供半胱氨酸结蛋白质的制剂,包括pH稳定的TGF-β超家族蛋白质和骨形态发生蛋白质。 特别地,本发明涉及某些缓冲液增强半胱氨酸结蛋白(包括TGF-β超家族蛋白和骨形态发生蛋白)的稳定性的观察。 特别地,本文公开的是用甘氨酰甘氨酸和酒石酸缓冲液制备的液体和冻干制剂,以稳定制剂的pH。

    Buffers for Controlling the pH of Bone Morphogenetic Proteins
    5.
    发明申请
    Buffers for Controlling the pH of Bone Morphogenetic Proteins 审中-公开
    缓释剂用于控制骨形态发生蛋白的pH值

    公开(公告)号:US20140336114A1

    公开(公告)日:2014-11-13

    申请号:US14088623

    申请日:2013-11-25

    摘要: The present invention provides formulations of cysteine knot proteins, including TGF-β superfamily proteins and bone morphogenic proteins that are pH stabilized. In particular, the present invention relates to the observation that certain buffers enhance the stability of cysteine knot proteins, including TGF-β superfamily proteins and bone morphogenic proteins. In particular, disclosed herein are liquid and lyophilized formulations prepared with a glycylglycine and tartaric acid buffers to stabilize the pH of the formulation.

    摘要翻译: 本发明提供了半胱氨酸结蛋白质的制剂,包括TGF- 超家族蛋白质和pH稳定的骨形态发生蛋白质。 特别地,本发明涉及某些缓冲液增强半胱氨酸结蛋白质的稳定性的观察,包括TGF- 超家族蛋白质和骨形态发生蛋白。 特别地,本文公开的是用甘氨酰甘氨酸和酒石酸缓冲液制备的液体和冻干制剂,以稳定制剂的pH。